|
Real-time Estimate
Cboe BZX
16:01:36 17/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 23.90 USD | +7.44% |
|
+5.42% | - |
| 09-16 | Attovia Therapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 10:00 AM | |
| 09-02 | Attovia Therapeutics Q2 Net Loss Widens | MT |
| Market Cap | 1.02B 880M 832M 755M 1.42B 97.44B 1.42B 9.93B 3.84B 49.42B 3.82B 3.73B 158B | P/E 2026 * |
-8.01x | P/E 2027 * | -10.6x |
|---|---|---|---|---|---|
| Enterprise Value | 637M 552M 522M 474M 887M 61.09B 893M 6.23B 2.41B 30.98B 2.39B 2.34B 98.76B | EV / Sales 2026 * |
1,365x | EV / Sales 2027 * | - |
| Free-Float |
91.15% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ATTO | Delayed | |
CBOE
| ATTO | Real-time |
Last Transcript: Attovia Therapeutics, Inc.
| 1 day | +7.44% | ||
| 1 week | +5.42% | ||
| Current month | +10.98% | ||
| 1 month | +4.58% |
| 1 week | 21.24 |  | 25.46 |
| 1 month | 18.85 | | 28 |
| Current year | 16.15 | | 28 |
| 1 year | 16.15 | | 28 |
| 3 years | 16.15 | | 28 |
| 5 years | 16.15 | | 28 |
| 10 years | 16.15 | | 28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hangjun Zhan
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/2022 |
Petter Veiby
CTO | Chief Tech/Sci/R&D Officer | 61 | 31/05/2023 |
Tao Fu
CEO | Chief Executive Officer | 54 | 31/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Aaron Royston
BRD | Director/Board Member | 42 | 31/05/2023 |
Tao Fu
BRD | Director/Board Member | 54 | 31/03/2023 |
James Topper
CHM | Chairman | 64 | 31/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 06/08/26 | Goldman Sachs & Co. LLC (Private Banking)
| Conversion | Company | 25,562,737 | 59.4081% | |
| 06/08/26 | Conversion | 1,865,710 | 4.3359% | |||
| 06/08/26 | Deep Track Capital LP
| Conversion | Company | 20,138,956 | 46.8032% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.44% | +5.42% | - | - | 1.02B | |
| +0.66% | +1.83% | +47.32% | +97.63% | 69.69B | |
| +1.86% | +1.00% | +37.82% | +77.06% | 61.24B | |
| +1.37% | -2.80% | -14.55% | +365.95% | 26.77B | |
| +0.32% | +2.58% | +29.26% | +14.12% | 26.12B | |
| +3.28% | +2.85% | +1.02% | -9.07% | 24.07B | |
| +1.49% | +8.02% | +27.19% | -13.56% | 20.39B | |
| 0.00% | -10.41% | +171.96% | +298.75% | 15.72B | |
| +2.24% | +0.54% | +42.78% | +170.44% | 14.07B | |
| +0.17% | -4.07% | -9.71% | +484.05% | 14.03B | |
| Average | +1.89% | -1.94% | +37.01% | +165.04% | 27.31B | |
| Weighted average by Cap. | +1.31% | -0.96% | +35.78% | +128.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 467K 404K 382K 347K 650K 44.77M 654K 4.56M 1.76M 22.71M 1.75M 1.71M 72.38M | - |
| Net income | -83.44M -72.31M -68.35M -62.05M -116M -8B -117M -816M -315M -4.06B -313M -306M -12.94B | -107M -92.85M -87.76M -79.67M -149M -10.28B -150M -1.05B -405M -5.21B -402M -394M -16.62B |
| Net Debt | -379M -328M -310M -282M -528M -36.35B -531M -3.71B -1.43B -18.44B -1.42B -1.39B -58.77B | -286M -248M -234M -213M -399M -27.45B -401M -2.8B -1.08B -13.92B -1.07B -1.05B -44.37B |
Employees
44
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/09/26 | US$23.70 | +6.53% | 38,068 |
| 16/09/26 | US$22.25 | -6.12% | 293,373 |
| 15/09/26 | US$23.70 | -3.34% | 198,402 |
| 14/09/26 | US$24.52 | +7.59% | 286,054 |
| 11/09/26 | US$22.79 | +1.15% | 175,769 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
22.25USD
Average target price
42.20USD
Spread / Average Target
+89.66%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATTO Stock
Select your edition
All financial news and data tailored to specific country editions
